To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD

Completed · Phase 3

Conditions studied: Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, Emphysema

In brief

The purpose of this study is to determine the long-term safety of arformoterol over a period of 12 months in subjects with COPD

Key facts

Study ID
NCT00064415
Run by
Sumitomo Pharma America, Inc.
People needed
799
Starts
2002-06-01
Expected to finish
2004-12-01
Last updated by the study team
2012-02-22

Who can join

Age: 35 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.